THIS NOVEL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a aggressive brain malignancy known for its rapid growth and insensitivity to standard treatments. Research are constantly underway to identify new treatment strategies, and recently, a new biomarker named LCA168 has emerged as a potential target for GBM treatment. LCA168 is a protein that is abundantly produced in glioblastoma cel